$112 Million is the total value of Mork Capital Management, LLC's 111 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPWH | New | SPORTSMAN'S WAREHOUSE HOLDINGS | $1,052,000 | – | 220,000 | +100.0% | 0.94% | – |
| GILD | New | GILEAD SCIENCES INC | $1,019,000 | – | 15,000 | +100.0% | 0.91% | – |
| ESRX | New | EXPRESS SCRIPTS HOLDING COMPANY | $989,000 | – | 15,000 | +100.0% | 0.88% | – |
| TEVA | New | TEVA PHARMACEUTICAL -SP ADRadrs | $963,000 | – | 30,000 | +100.0% | 0.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AIR LEASE CORPORATION CL A | 36 | Q3 2023 | 2.7% |
| APPLE INC | 36 | Q3 2023 | 3.1% |
| FEDEX CORP | 36 | Q3 2023 | 2.9% |
| ALPHA & OMEGA SEMICONDUCTOR | 36 | Q3 2023 | 3.2% |
| METLIFE INC | 36 | Q3 2023 | 1.7% |
| ACME UTD CORP | 36 | Q3 2023 | 2.3% |
| INTL BUSINESS MACHINES CORP | 36 | Q3 2023 | 1.7% |
| LYONDELLBASELL INDUSTRIES N | 36 | Q3 2023 | 1.1% |
| UNITED THERAPEUTICS CORP DEL | 36 | Q3 2023 | 1.2% |
| GENERAL MTRS CO | 34 | Q3 2023 | 1.8% |
View Mork Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13D/A | 2024-01-23 |
| SC 13D/A | 2023-11-17 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2023-01-20 |
| 13F-HR | 2022-11-14 |
View Mork Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.